Trading Signals: FOLD Stock Price Prediction and Forecast (Thu. May. 31, 2007 - Fri. Dec. 22, 2023)(Amicus Therapeutics Inc)
| FOLD latest price $12.6650 (0.56%) ($12.6650 - $12.6650) on Thu. Jun. 8, 2023. | |
| | Trend Analysis and Forecast | | | Average Daily Percentage Swing | 2.3% (three month average) | RSI | 70 | Latest Price | $12.6650(0.56%) | Stocks Behave Similarly | Similar Stock List | Daily Trend | FOLD advances 2.2% a day on average for past five trading days. | Weekly Trend | FOLD advances 3.6% a week on average for past two weeks. | Market Behavior | Growth stock rally for large cap. Value stock sell-off for small cap. | Correlated ETFs | Broad market will support FOLD advance at 0% a week (0% probability) XBI(62%) IBB(58%) IWM(44%) IWO(44%) IWN(41%) | Factors Impacting FOLD price | FOLD will decline at least -1.15% in a week (0% probabilities). TBT(-29%) VXX(-12%) UUP(-12%) BNDX(-4%) VIXM(-3%) | Explanation | The rally is not sustainable and not supported by the broad market. | | | | | Relative Volatility | (options are extremely cheap) | | | Market Trend Strength | -1.15% (StdDev 2.3%) | Hourly BBV | 1 () | Intraday Trend | 0% | | | |
|
5 Day Moving Average | $12.44(1.81%) | 10 Day Moving Average | $11.86(6.79%) | 20 Day Moving Average | $11.66(8.62%) | To recent high | 0% | To recent low | 17.9% | Market Cap | $3.27b | | | | Amicus Therapeutics, Inc. is a biotechnology company focused on discovering, developing, and delivering medicines for people living with rare metabolic diseases. The company is committed to advancing and expanding a pipeline of medicines for rare metabolic diseases, including a rare disease gene therapy portfolio. Amicus Therapeutics has a portfolio of product opportunities including the first and only approved oral precision medicine for people living with Fabry disease who have amenable genetic variants; a novel, clinical-stage, treatment paradigm for Pompe disease; and a rare disease gene therapy portfolio. The company was founded on February 4, 2002 and is headquartered in Cranbury, NJ. |